Development Level

Tbio 12 | 11,445
Tchem 5 | 1,598
Tclin 2 | 613

IMPC Phenotype

abnormal bone structure 3 | 187
preweaning lethality, complete... 3 | 979
decreased bone mineral content 2 | 151
embryonic lethality prior to t... 2 | 278
abnormal embryo size 1 | 220
abnormal midbrain development 1 | 20
abnormal neural tube closure 1 | 46
abnormal retina morphology 1 | 71
decreased circulating potassiu... 1 | 20
decreased hemoglobin content 1 | 68
embryonic growth retardation 1 | 106
embryonic lethality prior to o... 1 | 239
increased body length 1 | 32
increased circulating potassiu... 1 | 29
increased mean corpuscular vol... 1 | 92
small superior vagus ganglion 1 | 74

Disease

ovarian cancer 13 | 8,520
Carcinoma 12 | 11,493
Cancer 10 | 2,499
glioblastoma 10 | 5,792
osteosarcoma 10 | 7,950
psoriasis 10 | 6,694
medulloblastoma, large-cell 9 | 6,241
atypical teratoid / rhabdoid tumor 8 | 5,112
lung cancer 7 | 4,740
Autosomal recessive predisposition 6 | 1,442
ependymoma 6 | 4,679
group 4 medulloblastoma 6 | 1,855
intraductal papillary-mucinous neoplasm (IPMN) 6 | 3,291
adult high grade glioma 5 | 3,801
Breast cancer 4 | 3,578
Kidney cancer 4 | 2,613
Pick disease 4 | 1,894
breast carcinoma 4 | 1,638
ductal carcinoma in situ 4 | 1,745
lung adenocarcinoma 4 | 2,716
malignant mesothelioma 4 | 3,232
non-small cell lung cancer 4 | 2,890
oligodendroglioma 4 | 2,850
primitive neuroectodermal tumor 4 | 3,035
subependymal giant cell astrocytoma 4 | 2,287
Intellectual disability 3 | 1,016
acute quadriplegic myopathy 3 | 1,158
astrocytic glioma 3 | 2,597
cystic fibrosis 3 | 1,696
dermatomyositis 3 | 966
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,989
tuberculosis 3 | 2,010
Asthma 2 | 385
Astrocytoma, Pilocytic 2 | 3,081
Autoimmune lymphoproliferative syndrome 2 | 11
Cerebral atrophy 2 | 178
Creatine phosphokinase serum increased 2 | 110
Degenerative brain disorder 2 | 100
Duchenne muscular dystrophy 2 | 601
Elevated creatine kinase 2 | 110
Endometriosis 2 | 540
Epilepsy 2 | 792
Leukemia 2 | 104
Melanoma 2 | 711
Muscle biopsy shows dystrophic changes 2 | 39
Muscular dystrophy 2 | 75
Myopathy 2 | 185
Neurodegenerative disease 2 | 414
Paraplegia 2 | 74
Prostatic Neoplasms 2 | 495
Seizures 2 | 596
Short stature 2 | 531
Supratentorial atrophy 2 | 94
aldosterone-producing adenoma 2 | 665
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 510
colon cancer 2 | 1,478
cutaneous lupus erythematosus 2 | 1,057
esophageal adenocarcinoma 2 | 737
group 3 medulloblastoma 2 | 4,104
interstitial cystitis 2 | 2,312
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,955
invasive ductal carcinoma 2 | 2,951
limb-girdle muscular dystrophy 2 | 37
lung carcinoma 2 | 2,843
medulloblastoma 2 | 720
pancreatic cancer 2 | 2,398
pituitary cancer 2 | 1,972
primary Sjogren syndrome 2 | 735
primary pancreatic ductal adenocarcinoma 2 | 1,109
progressive supranuclear palsy 2 | 676
'Curvilinear profiles' ultrastructurally in cells 1 | 5
'Rectilinear' profiles ultrastructurally 1 | 2
Abnormal nervous system electrophysiology 1 | 3
Adenocarcinoma 1 | 122
Atrophy 1 | 10
CEROID LIPOFUSCINOSIS, NEURONAL, 6 1 | 6
Carcinoma, Non-Small-Cell Lung 1 | 107
Carcinoma, Squamous Cell 1 | 110
Carcinoma, squamous cell of head and neck 1 | 31
Catecholaminergic polymorphic ventricular tachycardia 1 | 12
Ceroid Lipofuscinosis, Neuronal, 4A, Autosomal Recessive 1 | 1
Ceroid lipofuscinosis neuronal 6 1 | 2
Decreased visual acuity, progressive 1 | 36
Eosinophilia 1 | 28
Glioma 1 | 74
Granular osmiophilic deposits (GROD) in cells 1 | 1
Hyperglycemia 1 | 137
Increased hepatocellular carcinoma risk 1 | 27
Increased incidence of hepatocellular carcinoma 1 | 27
Increased neuronal autofluorescent lipopigment 1 | 7
Liver Neoplasms, Experimental 1 | 59
Malignant neoplasm of prostate 1 | 11
Malocclusion 1 | 57
Mask-like facies 1 | 25
Muscle atrophy, proximal 1 | 11
Neuronal lipopigments 1 | 7
Nonorganic psychosis 1 | 84
Progressive visual loss 1 | 36
Squamous cell carcinoma of the head and neck 1 | 29
Syndactyly of fingers 1 | 48

Tissue

Blood and immune system 19 | 16,909
Cardiovascular System 19 | 15,192
Digestive Tract 19 | 17,369
Endocrine System 19 | 18,159
Female tissues 19 | 17,400
Liver and Pancreas 19 | 16,750
Male tissues 19 | 17,142
Nervous System 19 | 16,725
Respiratory system 19 | 16,393
Skin and soft tissues 19 | 17,230
Urinary Tract 19 | 16,678

Target Family

Non-IDG 11 | 12,091
Enzyme 5 | 4,145
Kinase 2 | 634
Epigenetic 1 | 242

GO Process

positive regulation of proteol... 19 | 19
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Ceroid-lipofuscinosis neuronal protein 6 CLN6 Tbio Non-IDG -1.87357 0.00000 103
TBC1 domain family member 10A TBC1D10A Tbio Non-IDG -0.65759 0.00000 99
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OGT Tchem Enzyme -2.98896 993.7 264
Fibroblast growth factor receptor 4 FGFR4 Tclin Kinase -2.44255 276.4 502
Bcl2-associated agonist of cell death BAD Tchem Non-IDG -2.08893 103.4 2565
Cytoplasmic FMR1-interacting protein 2 CYFIP2 Tbio Non-IDG -1.50813 23.0 99
Calpain-3 CAPN3 Tbio Non-IDG -2.45065 293.3 110
Bcl-2 homologous antagonist/killer BAK1 Tbio Non-IDG -2.29199 175.9 554
p53 apoptosis effector related to PMP-22 PERP Tbio Non-IDG -2.35251 224.2 191
IST1 homolog IST1 Tbio Non-IDG -1.46721 14.8 61